Prognostic Factors and the Impact of Various Management of Acute Myeloid Leukemia in Real Life Condition (LAM-BDD)

Toulouse University Hospital

Status: Active, not recruiting

Conditions: Acute Myeloid Leukemia

Treatments: Drug: intensive chemotherapy; Drug: Azacitidine

Study type: Observational

Funder types: Other

Identifiers

NCT03284593

14 7344 03

Details and patient eligibility

About

The treatment of older patients with acute myeloid leukemia that is secondary to previous myelodysplastic syndrome, myeloproliferative neoplasm, or prior cytotoxic exposure remains unsatisfactory. We compared patients treated with intensive chemotherapy or azacitidine within two centres.

Enrollment: 199 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• patients with acute myeloid leukemia

Trial design

199 participants in 2 patient groups

intensive chemotherapy group

Description:

patients treated with intensive chemotherapy

Treatment:

Drug: intensive chemotherapy

Azacitidine group

Description:

patients treated with azacitidine

Treatment:

Drug: Azacitidine